Health-adjusted premium subsidies in The Netherlands: As it implements managed competition, the Dutch government has taken steps to avoid risk selection in its sickness funds

Health Affairs

Volumn 23, Issue 3, 2004, Pages 45-55

  Van De Ven, Wynand P M M ^a   Van Vliet, René C J A ^b   Lamers, Leida M ^b  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b Department of Health Insurance ^*

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMPETITION; CONSUMER; DEMOGRAPHY; DIAGNOSTIC PROCEDURE; DRUG COST; DRUG INDUCED DISEASE; DRUG SAFETY; FINANCIAL MANAGEMENT; GOVERNMENT; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HEALTH HAZARD; HIGH RISK PATIENT; HOSPITAL CHARGE; MEDICAL RESEARCH; NETHERLANDS; OUTPATIENT CARE; PRESCRIPTION; PUBLIC HEALTH SERVICE; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SUSTAINABLE DEVELOPMENT;

FEES AND CHARGES; HUMANS; INSURANCE, HEALTH; MANAGED COMPETITION; NETHERLANDS; PHARMACEUTICAL SERVICES; RISK ADJUSTMENT;

EID: 2442566782     PISSN: 02782715     EISSN: None     Source Type: Journal    
DOI: 10.1377/hlthaff.23.3.45     Document Type: Article

References (27)

1. A.C. Enthoven, The Theory and Practice of Managed Competition (Amsterdam: North-Holland, Elsevier, 1988).
2. F.T. Schut and W.P.M.M. van de Ven, "Rationing and Competition in the Dutch Health Care System" (Paper prepared for the IMPACT Project, London School of Economics, December 2002); and J.K. Helderman et al., "Market-Oriented Health Care Reforms and Policy Learning in the Netherlands" (Unpublished paper, Erasmus University Rotterdam, 21 March 2003).
3. F.T. Schut and W.P.M.M. van de Ven, "Rationing and Competition in the Dutch Health Care System" (Paper prepared for the IMPACT Project, London School of Economics, December 2002); and J.K. Helderman et al., "Market-Oriented Health Care Reforms and Policy Learning in the Netherlands" (Unpublished paper, Erasmus University Rotterdam, 21 March 2003).
4. W.P.M.M. van de Ven et al., "Risk-Adjusted Capitation: Recent Experiences in the Netherlands," Health Affairs 13, no. 4 (1994): 118-136.
5. L. Nelson et al., "Access to Care in Medicare HMOs, 1996," Health Affairs 16, no. 2 (1997): 148-156; G.F. Riley, M.J. Ingber, and C.G. Tudor, "Disenrollment of Medicare Beneficiaries from HMOs," Health Affairs 16, no. 5 (1997): 117-124; J.E. Ware et al., "Differences in Four-Year Health Outcomes for Elderly and Poor, Chronically Ill Patients Treated in HMO and Fee-for-Service Systems," Journal of the American Medical Association 276, no. 13 (1996): 1039-1047; K. Davis and C. Schoen, "Assuring Quality, Information, and Choice in Managed Care," Inquiry 35, no. 2 (1998): 104-114; and R.H. Miller, "Health Care Organizational Change: Implications for Access to Care and Its Measurement," Health Services Research 33, no. 3, Part 2 (1998): 653-680.
6. L. Nelson et al., "Access to Care in Medicare HMOs, 1996," Health Affairs 16, no. 2 (1997): 148-156; G.F. Riley, M.J. Ingber, and C.G. Tudor, "Disenrollment of Medicare Beneficiaries from HMOs," Health Affairs 16, no. 5 (1997): 117-124; J.E. Ware et al., "Differences in Four-Year Health Outcomes for Elderly and Poor, Chronically Ill Patients Treated in HMO and Fee-for-Service Systems," Journal of the American Medical Association 276, no. 13 (1996): 1039-1047; K. Davis and C. Schoen, "Assuring Quality, Information, and Choice in Managed Care," Inquiry 35, no. 2 (1998): 104-114; and R.H. Miller, "Health Care Organizational Change: Implications for Access to Care and Its Measurement," Health Services Research 33, no. 3, Part 2 (1998): 653-680.
7. L. Nelson et al., "Access to Care in Medicare HMOs, 1996," Health Affairs 16, no. 2 (1997): 148-156; G.F. Riley, M.J. Ingber, and C.G. Tudor, "Disenrollment of Medicare Beneficiaries from HMOs," Health Affairs 16, no. 5 (1997): 117-124; J.E. Ware et al., "Differences in Four-Year Health Outcomes for Elderly and Poor, Chronically Ill Patients Treated in HMO and Fee-for-Service Systems," Journal of the American Medical Association 276, no. 13 (1996): 1039-1047; K. Davis and C. Schoen, "Assuring Quality, Information, and Choice in Managed Care," Inquiry 35, no. 2 (1998): 104-114; and R.H. Miller, "Health Care Organizational Change: Implications for Access to Care and Its Measurement," Health Services Research 33, no. 3, Part 2 (1998): 653-680.
8. L. Nelson et al., "Access to Care in Medicare HMOs, 1996," Health Affairs 16, no. 2 (1997): 148-156; G.F. Riley, M.J. Ingber, and C.G. Tudor, "Disenrollment of Medicare Beneficiaries from HMOs," Health Affairs 16, no. 5 (1997): 117-124; J.E. Ware et al., "Differences in Four-Year Health Outcomes for Elderly and Poor, Chronically Ill Patients Treated in HMO and Fee-for-Service Systems," Journal of the American Medical Association 276, no. 13 (1996): 1039-1047; K. Davis and C. Schoen, "Assuring Quality, Information, and Choice in Managed Care," Inquiry 35, no. 2 (1998): 104-114; and R.H. Miller, "Health Care Organizational Change: Implications for Access to Care and Its Measurement," Health Services Research 33, no. 3, Part 2 (1998): 653-680.
9. L. Nelson et al., "Access to Care in Medicare HMOs, 1996," Health Affairs 16, no. 2 (1997): 148-156; G.F. Riley, M.J. Ingber, and C.G. Tudor, "Disenrollment of Medicare Beneficiaries from HMOs," Health Affairs 16, no. 5 (1997): 117-124; J.E. Ware et al., "Differences in Four-Year Health Outcomes for Elderly and Poor, Chronically Ill Patients Treated in HMO and Fee-for-Service Systems," Journal of the American Medical Association 276, no. 13 (1996): 1039-1047; K. Davis and C. Schoen, "Assuring Quality, Information, and Choice in Managed Care," Inquiry 35, no. 2 (1998): 104-114; and R.H. Miller, "Health Care Organizational Change: Implications for Access to Care and Its Measurement," Health Services Research 33, no. 3, Part 2 (1998): 653-680.
10. E.M. van Barneveld, R.C.J.A. van Vliet, and W.P.M.M. van de Ven, "Risk Sharing between Competing Health Plans and Sponsors," Health Affairs 20, no. 3 (2001): 253-262; and R.C.J.A. van Vliet, "A Statistical Analysis of Mandatory Pooling across Health Insurance," Journal of Risk Insurance 67, no. 2 (2000): 197-217.
11. E.M. van Barneveld, R.C.J.A. van Vliet, and W.P.M.M. van de Ven, "Risk Sharing between Competing Health Plans and Sponsors," Health Affairs 20, no. 3 (2001): 253-262; and R.C.J.A. van Vliet, "A Statistical Analysis of Mandatory Pooling across Health Insurance," Journal of Risk Insurance 67, no. 2 (2000): 197-217.
12. L.M. Lamers, R.C.J.A. van Vliet, and W.P.M.M. van de Ven, "Risk Adjusted Capitation Payment System for Health Insurance Plans in a Competitive Market," Expert Review Pharmacoeconomics Outcomes Research 3, no. 5 (2003): 541-549.
13. WHO Collaborating Centre for Drug Statistics Methodology, "Anatomical Therapeutic Chemical (ATC) Classification Index" (Oslo: WHO Collaborating Centre for Drug Statistics Methodology, 2000).
14. D.O. Clark et al., "A Chronic Disease Score with Empirically Derived Weights," Medical Care 33, no. 8 (1995): 783-795.
15. L.M. Lamers, R.C.J.A. van Vliet, and W.P.M.M. van de Ven, "Pharmacy-Based Cost Groups: A Risk Adjuster for Capitation Payments Based on the Utilization of Prescribed Drugs" (in Dutch) (Rotterdam: Department of Health Policy and Management, Erasmus University, 1999).
16. L.M. Lamers and R.C.J.A. van Vliet, "The Pharmacy-Based Cost Group Model: Validating and Adjusting the Classification of Medication for Chronic Conditions for the Dutch Situation," Health Policy (forthcoming).
17. L.M. Lamers and R.C.J.A. van Vliet, "Health-Based Risk Adjustment: Improving the Pharmacy-Based Cost Group Model to Reduce Planning Possibilities," European Journal of Health Economics 4, no. 2 (2003): 107-114.
18. T. Gilmer et al., "The Medicaid Rx Model: Pharmacy-Based Risk Adjustment for Public Programs," Medical Care 39, no. 11 (2001): 1188-1202.
19. G.C. Pope et al., "Principal Inpatient Diagnostic Cost Group Model for Medicare Risk Adjustment," Health Care Financing Review 21, no. 3 (2000): 93-118.
20. L.M. Lamers, R.C.J.A. van Vliet, and W.P.M.M. van de Ven, "Risk Adjusted Premium Subsidies and Risk Sharing: Key Elements of the Competitive Sickness Fund Market in the Netherlands," Health Policy 65, no. 1 (2003): 49-62.
21. W.P.M.M. van de Ven et al., "Risk Adjustments and Risk Selection on the Sickness Fund Insurance Market in Five European Countries," Health Policy 65, no. 1 (2003): 75-98.
22. L.M. Lamers and R.C.J.A. van Vliet, "Multiyear Diagnostic Information from Prior Hospitalization as a Risk-Adjuster for Capitation Payments," Medical Care 34, no. 6 (1996): 549-561.
23. W.P.M.M. van de Ven and R.P. Ellis, "Risk Adjustment in Competitive Health Plan Markets," in Handbook of Health Economics, vol. 1, ed. AJ. Culyer and J.P. Newhouse (Amsterdam: Elsevier Science BV, 2000), 755-845.
24. For the complications in case of a voluntary deductible in the context of a demographic risk adjustment model, see, for example, K. Beck, S. Spycher, and A. Holly, "Risk Adjustment in Switzerland," Health Policy 65, no. 1 (2003): 63-74.
25. For a discussion on this issue, see, for example, W McClure, "On the Research Status of Risk-Adjusted Capitation Rates," Inquiry 21, no. 3 (1984): 205-213; H.S. Luft, "Modifying Managed Competition to Address Costs and Quality," Health Affairs 15, no. 1 (1996): 23-38; and van de Ven and Ellis, "Risk Adjustment in Competitive Health Plan Markets," 782.
26. For a discussion on this issue, see, for example, W McClure, "On the Research Status of Risk-Adjusted Capitation Rates," Inquiry 21, no. 3 (1984): 205-213; H.S. Luft, "Modifying Managed Competition to Address Costs and Quality," Health Affairs 15, no. 1 (1996): 23-38; and van de Ven and Ellis, "Risk Adjustment in Competitive Health Plan Markets," 782.
27. For a discussion on this issue, see, for example, W McClure, "On the Research Status of Risk-Adjusted Capitation Rates," Inquiry 21, no. 3 (1984): 205-213; H.S. Luft, "Modifying Managed Competition to Address Costs and Quality," Health Affairs 15, no. 1 (1996): 23-38; and van de Ven and Ellis, "Risk Adjustment in Competitive Health Plan Markets," 782.